Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
angiogenesis
Correlation of Angiogenesis With 18F-FMT and 18F-FDG Uptake in Non-Small Cell Lung Cancer
1 other identifier
observational
N/A
1 country
1
Brief Summary
Purpose: L-\[3-18F\]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET. We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in the patients with non-small cell lung cancer (NSCLC). Method: Thirty-seven NSCLC patients were enrolled in this study, and a pair of PET study with 18F-FMT and 18F-FDG was performed. Uptake of PET tracers was evaluated with standardized uptake value. VEGF, CD31, CD34, LAT1 and Ki-67 labeling index of the resected tumors were analyzed by immunohistochemical staining, and correlated with the clinicopathologic variables and the uptake of PET tracers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2008
CompletedFirst Posted
Study publicly available on registry
May 5, 2008
CompletedMay 5, 2008
January 1, 2008
April 30, 2008
May 2, 2008
Conditions
Keywords
Study Arms (2)
I
L-\[3-18F\]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET. We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in the patients with non-small cell lung cancer
Nuclear
Eligibility Criteria
You may qualify if:
- Patients who underwent a thoracotomy within 4 weeks after 18F-FMT PET and 18F-FDG PET study
- Histology is non-small cell lung cancer
You may not qualify if:
- Patient who received neoadjuvant chemotherapy or radiotherapy before surgery
- Patients who have insulin-dependent diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gunma Universitylead
- J~pharmacollaborator
Study Sites (1)
Gunma University Graduate School of Medicine
Showa-machi, Maebashi, Gunma, 371-8511, Japan
Related Publications (1)
Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci. 2009 Apr;100(4):753-8. doi: 10.1111/j.1349-7006.2008.01077.x. Epub 2009 Jan 12.
PMID: 19141127DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 30, 2008
First Posted
May 5, 2008
Last Updated
May 5, 2008
Record last verified: 2008-01